EP3003284
Lyfjaform af HIF hýdroxýlasahemli
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
5.6.2014EP published:
12.2.2020EP application number:
14735770.1
EP translation filed:
30.3.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
4.6.2034Expiry date:
4.6.2025
Title:
PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
Timeline
Today
5.6.2014EP application
12.2.2020EP Publication
30.3.2020Translation submitted
15.7.2020Registration published
4.6.2025Expires
Owner
Name:
Fibrogen, Inc.Address:
409 Illinois Street, San Francisco, CA 94158, US
Inventor
Name:
CONCA, DavidAddress:
San Francisco, CA 94158, US
Name:
FLIPPIN, Lee, AllenAddress:
San Francisco, CA 94158, US
Name:
LEIGH, Scott, DavidAddress:
San Francisco, CA 94158, US
Name:
WITSCHI, ClaudiaAddress:
San Francisco, CA 94158, US
Name:
WRIGHT, Lee, RobertAddress:
San Francisco, CA 94158, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361831909 PDate:
6.6.2013Country:
US
Classification
Categories:
A61K 9/28, A61K 9/48, A61K 31/472, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.7.2020
Expires: 4.6.2021
Payer: Patice ehf.
Number: 8
Paid: 8.6.2021
Expires: 4.6.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.5.2022
Expires: 4.6.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 24.5.2023
Expires: 4.6.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 21.5.2024
Expires: 4.6.2025
Payer: Árnason Faktor ehf.